GHRS

GH Research PLC - Ordinary Shares (GHRS)

About GH Research PLC - Ordinary Shares (GHRS)

GH Research Plc is a holding company, which engages in the provision of biopharmaceutical products and services. It develops therapeutic products for patients with psychiatric and neurological disorders. The firm develops novel and proprietary 5-Methoxy-N and N-Dimethyltryptamine, or 5-MeO-DMT, therapies. The company was founded by Theis Terwey, Florian Schönharting, and Magnus Halle in 2018 and is headquartered in Dublin, Ireland.

Details

Daily high

$28.49

Daily low

$27.76

Price at open

$28.48

52 Week High

$31.44

52 Week Low

$12.04

Market cap

1.9B

Dividend yield

Volume

103,016

Avg. volume

182,345

P/E ratio

-28.62

GH Research PLC - Ordinary Shares News